International Registration for Medical Devices & IVDs
Bringing a medical device or IVD to international markets requires far more than submitting the same file everywhere. Each jurisdiction has its own classification rules, documentation expectations, approval pathways, and post-market obligations. Syrma Johari MedTech helps manufacturers navigate this complexity through integrated international registration support across 50+ countries — combining regulatory strategy, technical documentation, testing readiness, and lifecycle compliance under one roof.
Global Expansion Demands More Than Local Submissions
International registration is a portfolio of country-specific and region-specific market authorizations, each governed by distinct frameworks. Manufacturers must manage fragmented requirements, shifting compliance expectations, varied classification systems, and multiple submission formats — while also maintaining consistent product evidence and post-market controls across markets. For IVD companies, the challenge is even greater, as analytical and clinical performance expectations often vary significantly between jurisdictions.
Fragmented Regulatory Frameworks
Different markets follow different regulatory models, from FDA clearance and approval pathways to EU MDR/IVDR, CDSCO import licensing, and UK reliance routes.
Variable Classification & Evidence Requirements
The same product may fall into different classes in different markets, changing the level of review, data, and conformity assessment needed.
Country-Specific Dossiers & Representation
Manufacturers must prepare jurisdiction-specific technical files while also coordinating local agents, authorized representatives, sponsors, or importers.
Ongoing Multi-Market Compliance
Registration does not end at approval. Post-market surveillance, vigilance reporting, renewals, and change control must remain synchronized globally.
A Strategic Pathway to Multi-Country Market Authorization
International registration is the process of securing market authorization across multiple countries through national, regional, and reliance-based pathways. It is not a single global approval, but a strategic sequence of registrations such as FDA clearance in the US, CE marking in Europe, CDSCO import licensing in India, and country-specific approvals across Asia-Pacific, Latin America, and the Middle East. Modern registration strategies increasingly leverage harmonized regulatory principles, IMDRF guidance, WHO-aligned frameworks, and reliance pathways based on approvals from trusted reference markets.
- Risk-based classification
- Essential safety and performance principles
- Jurisdiction-specific conformity pathways
- Technical documentation alignment
- Post-market compliance and lifecycle maintenance
Different Registration Logic for Devices and IVDs
Why IVD international registration requires a more tailored evidence and sequencing strategy.
Medical devices and IVDs share core regulatory foundations, but IVD registration often involves additional complexity. IVD classification is strongly influenced by the impact of an incorrect diagnostic result on patient care and public health, making evidence requirements more stringent for higher-risk categories. Under EU IVDR, many moderate- and high-risk IVDs now require Notified Body involvement, increasing review timelines and documentation depth. In India and other markets, IVD submissions often require detailed Device Master Files, Plant Master Files, stability data, and analytical or clinical performance evidence. This makes evidence planning and market sequencing especially important for IVD portfolios.
Medical Devices
Focused on safety, performance, intended use, design controls, manufacturing validation, risk management, and clinical evidence where applicable.
IVDs
Require all core device elements plus analytical performance, clinical performance, stability evidence, traceability, and intended-use validation across target populations.
International Registration Integrated with Design, Manufacturing & Quality
Unlike standalone regulatory consultancies, Syrma Johari MedTech delivers international registration as part of an integrated MedTech ecosystem. Our regulatory strategy begins during design control and product architecture, helping manufacturers build regulatory readiness into the product early rather than retrofitting documentation later. Design history, technical files, manufacturing traceability, verification and validation evidence, and quality documentation flow directly from our operating systems into registration dossiers — reducing handoff risk, improving submission quality, and accelerating timelines.
Design-Led Regulatory Readiness
Registration strategy begins early in development, helping align product architecture, documentation, and evidence generation from the start.
Integrated Quality Systems
DHFs, technical documentation, manufacturing records, and validation evidence are developed within a controlled quality framework.
Testing & Manufacturing Alignment
Regulatory-grade evidence is supported by manufacturing and testing infrastructure, not assembled retrospectively.
Single-Partner Execution
Reduce fragmentation, improve communication, and avoid the delays common in multi-vendor registration programs.
Built on Proven Quality, Testing & Regulatory Infrastructure
Our international registration capability is backed by ISO 13485 and MDSAP-certified quality systems, established design controls, in-house testing support, and proven submission experience across major and emerging markets. This enables SJML to support manufacturers from initial assessment through submission management, approval coordination, and post-market lifecycle compliance.
50+ Countries
- Registration support across major and emerging markets
20 FDA 510(k) Clearances
- Proven experience with US medical device submissions
60+ CDSCO Licenses
- Medical device and IVD registration support in India
ISO 13485 & MDSAP Frameworks
- Quality systems aligned to global regulatory expectations
Why Manufacturers Partner with SJML
United States
Support for 510(k), De Novo, PMA, classification strategy, DHF readiness, QSR alignment, establishment registration, device listing, Q-Submissions, and US Agent coordination.
Canada
Medical Device License and Establishment License support, IMDRF-aligned technical documentation, bilingual labeling, and MDSAP-linked compliance execution.
European Union
CE marking support under MDR and IVDR, classification, GSPR mapping, Annex II/III technical documentation, CER/PER development, Notified Body coordination, EUDAMED strategy, PMS, and PSUR support.
United Kingdom
Support across MHRA recognition and reliance pathways, UK Responsible Person coordination, UK-specific labeling, documentation alignment, and PMS readiness.
Switzerland
Swissmedic-aligned registration strategy including CH-REP coordination, MedDO/IvDO classification, and post-market compliance support.
India
End-to-end CDSCO support including classification, DMF/PMF compilation, authorized agent coordination, import license management, and performance or stability study support for IVDs.
Asia-Pacific
Support for China, Australia, South Korea, and other regional markets through local representation, technical documentation adaptation, review coordination, and country-specific compliance planning.
Latin America / Middle East / Africa
Registration support across Brazil, Mexico, Colombia, Argentina, UAE, Saudi Arabia, Turkey, Egypt, Israel, Nigeria, Kuwait, and GCC markets through locally adapted regulatory strategies.
A Structured, Phased Approach to Global Registration
Strategic Regulatory Assessment
We evaluate your device or IVD, intended use, target markets, and commercial priorities to define optimal registration sequencing and identify opportunities to leverage reference approvals.
Gap Analysis & Readiness Planning
We assess your design controls, QMS, technical files, testing, labeling, and evidence against target-market requirements to identify remediation or readiness needs.
Technical Documentation Development
We build a master dossier aligned to global frameworks, covering device description, intended use, classification rationale, risk management, V&V, biocompatibility, software documentation, labeling, and PMS planning.
Submission Management & Authority Liaison
We prepare jurisdiction-specific submissions, coordinate in-country representation, manage authority queries, and support meetings such as FDA Pre-Subs or other regulator interactions.
Approval & Launch Readiness
We support UDI implementation, registration listings, labeling verification, import readiness, and launch documentation for distribution and commercialization.
Post-Market Lifecycle Management
We help maintain registrations through vigilance reporting, change control, renewals, surveillance support, and regulatory intelligence across registered markets.
Why Choose Syrma Johari MedTech for International Registration
Global Regulatory Breadth
- Deep experience across FDA, EU MDR/IVDR, UK MHRA, CDSCO, and multiple Asia-Pacific, Latin American, and Middle East markets.
Integrated Testing & Manufacturing Support
- Registration is strengthened by aligned quality systems, technical documentation, and evidence generation capabilities linked to product realization.
Experience with Complex Products
- Support for high-risk devices, software-enabled platforms, advanced IVDs, and products requiring more demanding review pathways.
First-Time-Right Submission Focus
- Strong planning, disciplined documentation, and multi-market strategy help reduce avoidable review cycles and accelerate approvals.
Success Stories
High-Risk Monitoring Device for Multi-Region Launch
For a Class III critical care monitoring system, SJML built a unified registration strategy across the US, EU, UK, India, and Australia. By aligning design controls, clinical evidence, and quality systems early, the program supported parallel regulatory progress across multiple markets and reduced total time-to-global-market compared with a sequential country-by-country approach.
IVD Portfolio Transition to IVDR with Asia-Pacific Expansion
For an immunoassay and reagent portfolio moving from IVDD to IVDR, SJML led the gap assessment, evidence planning, and dossier strategy needed for EU certification while also supporting expansion into India, China, and Australia. A unified evidence package reduced duplicate validation work and improved overall efficiency across the program.
Take the Next Step Toward Global Market Access
International registration should not become the barrier that delays meaningful medical innovation. With integrated regulatory, quality, testing, and product support capabilities, Syrma Johari MedTech helps manufacturers move from fragmented submissions to a more structured and scalable global market access strategy.
Whether you are preparing for your first overseas expansion, transitioning products to EU MDR or IVDR, or planning multi-country commercialization, our team can help you reduce regulatory risk and accelerate readiness across target markets.
Information Center
Which market should we target first for international registration?
The right sequencing depends on your commercial priorities, device risk, competitive context, and available evidence. In many cases, manufacturers benefit from securing an anchor approval such as FDA authorization or EU CE marking first, then leveraging that approval for reliance or recognition pathways in other jurisdictions.
Can we reuse clinical or performance data across multiple markets?
Yes, when the evidence strategy is planned correctly. Clinical, analytical, and performance data can often be structured for multi-market use, though some jurisdictions may still require supplemental local or intended-use-specific evidence.
What are realistic timelines for global registration?
Timelines vary by device class, market, and pathway. Lower-risk products may move through some markets in 6–12 months, while high-risk devices, advanced IVDs, or products requiring clinical evidence may take considerably longer.
What is the role of the manufacturer versus the regulatory partner?
The manufacturer retains legal responsibility for the product, quality system, and underlying technical information. SJML supports strategy, documentation, submission management, authority liaison, and lifecycle compliance execution.
How do we maintain approvals as the product evolves?
Global registrations must be actively managed as products change. Design changes, site transfers, labeling updates, and new indications may trigger notifications, supplements, or new submissions depending on the jurisdiction. A structured lifecycle approach helps maintain compliance across markets.
Capabilities
- Design and Development
- Engineering
- Contract Manufacturing
- QARA Services
- Product Lifecycle Management
- Medical PCB Assembly
- Medical Plastics Manufacturing
Market Segments
- IVD & Laboratory Diagnostics
- Medical Aesthetics
- Rehabilitation and Physical Therapy
- Patient Monitoring
- Drug Delivery
- Critical Care
- Surgical and Interventional Care
- Point of Care
COMPANY
- About Us
- Leadership
- Certifications and Awards
- ESG and Sustainibility
LEGAL
- CSR Policy
- Privacy Policy
- Terms & Conditions
- Terms of Use
CONTACT US
- Contact us
- Careers
MADE IN INDIA FOR THE WORLD